A second generation autologous chairside preparation (platelet concentrate) derived from whole venous blood through a specific process of gradient density centrifugation that limits the degree of blood manipulation, and does not require a platelet activator.
It produces dense fibrin matrix that incorporate leukocytes, platelets and high concentrations of growth factors.
When compressed, the resulting fibrin matrix is strong, pliable, and can be sutured for use as a stand-alone product to improve wound healing and promote tissue regeneration.
The resulting matrix can also be incorporated into particulate bone graft materials to improve handling characteristics of the particulate material.
Sign Up for Our Newsletter
ICOI is not only the world’s largest dental implant organization — we’re also the world’s largest provider of ongoing dental implant education! Learn more by signing up for our newsletter.